Scottish National Investment Bank

iGii makes Gii, a three-dimensional porous carbon nanomaterial, and develops industrial sensing, heating and battery-electrode applications from it.

Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease.

Develops full-spectrum microbiome therapeutics for gastrointestinal diseases including IBS